Information  X 
Enter a valid email address

Puma VCT 13 PLC (PU13)


Monday 17 May, 2021

Puma VCT 13 PLC

Issue of Equity

RNS Number : 8917Y
Puma VCT 13 PLC
17 May 2021


Puma VCT 13 plc


17 May 2021


Issue of Equity


The Directors of Puma VCT 13 plc (the "Company") are pleased to announce that further to an offer for subscription (the "Offer") of ordinary shares of £0.0005 each in the Company ("Ordinary Shares") to raise up to £7,500,000, together with an over-allotment facility for up to a further £2,500,000 as set out in a prospectus dated 9 October 2020, the Company has today made a final allotment of 180,683 Ordinary Shares pursuant to the Offer.


The offer price at which the Ordinary Shares were allotted was £1.165 per Ordinary Share, in accordance with the terms of the Offer.


The Offer is now closed to further applications. 


Following this allotment, a total of 8,684,558 Ordinary Shares have been issued by the Company pursuant to the Offer and the total number of Ordinary Shares in issue is 28,163,730.  Therefore, the total number of voting rights in the Company is 28,163,730. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.


Application will be made for the Ordinary Shares so allotted to be admitted to the Official List of the FCA and to trading on the London Stock Exchange's main market for listed securities, and dealings are expected to commence on or around 19 May 2021. Definitive documents of title are expected to be despatched within 10 business days of allotment.



For further information please contact:


Graham Shore

Puma VCT 13 plc

020 7408 4050


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t